Cytarabine (Cytosar-U)

A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
Also Known As:
Cytosar-U; Cytosine Arabinoside; Aracytidine; Aracytine; Cytarabine Hydrochloride; Cytonal; Cytosar; beta-Ara C; Arabinoside, Cytosine; Cytosar U; CytosarU; Hydrochloride, Cytarabine; Ara-C; Arabinofuranosylcytosine; Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-
Networked: 4912 relevant articles (664 outcomes, 866 trials/studies)

Relationship Network

Drug Context: Research Results